In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific Corporation

http://www.bostonscientific.com

Latest From Boston Scientific Corporation

Pharma Execs Jumping Onboard Private Equity Train

More C-Suite level pharma executives are lending their domain expertise to private equity firms, which then use their skills for commercial due diligence on targets or in an operating partner role in portfolio companies once a deal is sealed. PEs are also increasingly opting for control deals, at least in India, with an aim to run the acquired firm professionally thereon.

India Commercial

Supply Concerns As India Fast Tracks COVID-19 Vaccines Approved By Certain Regulators

In an unusual move prompted by an enormous second wave of infections, India is accelerating approvals for COVID-19 vaccines granted emergency use authorizations by other selected regulators or on the WHO’s emergency use list without a local bridging study. While this seems a prelude to permitting private sales, where will the supplies come from?

India Coronavirus COVID-19

Supply Concerns As India Fast Tracks COVID-19 Vaccines Approved By Certain Regulators

In an unusual move prompted by an enormous second wave of infections, India is accelerating approvals for COVID-19 vaccines granted emergency use authorizations by other selected regulators or on the WHO’s emergency use list without a local bridging study. While this seems a prelude to permitting private sales, where will the supplies come from?

India Coronavirus COVID-19

J&J, Pfizer To Gain As India Fast Tracks COVID-19 Vaccines Approved By Other Regulators

J&J and Pfizer should benefit from India’s unusual move to grant accelerated approvals minus a prior local bridging study for COVID-19 vaccines granted emergency use authorizations by certain regulators or on the WHO’s emergency use list. But while this seems like a prelude to permitting private sales, where will the supplies come from?

Policy & Regulation Coronavirus COVID-19
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Monitoring Equipment & Devices
    • Radiofrequency Devices
    • Rehabilitation Equipment and Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
    • Diagnostic Imaging Equipment & Supplies
      • Digital Imaging
  • Other Names / Subsidiaries
    • Apama Medical
    • Asthmatx
    • Atritech, Inc.
    • Augmenix, Inc.
    • Biocompatibles International plc
    • BridgePoint Medical, Inc.
    • BTG plc
    • BTG Specialty Pharmaceuticals
    • Cameron Health, Inc.
    • Cardiovascular Imaging Systems, Inc.
    • CellMed
    • Cosman Medical Inc.
    • CryoCor
    • Cryterion Medical, Inc.
    • Ekos Corporation
    • EMcision, Ltd.
    • EndoTex Interventional Systems, Inc.
    • EndoChoice Holdings, Inc.
    • Enteric Medical Technologies, Inc.
    • Galil Medical, Inc.
    • Guidant Corporation
    • Intelect Medical, Inc.
    • IoGyn, Inc.
    • Labcoat Limited
    • Meadox Medicals, Inc.
    • Novate Medical Ltd.
    • nVision Medical Corporation
    • NxThera, Inc.
    • Pathworks Anatomic Pathology Laboratory
    • PneumRx Inc.
    • Precision Vascular Systems, Inc.
    • Protherics PLC
    • RadioTherapeutics Corporation
    • Revascular Therapeutics, Inc.
    • Roxwood Medical
    • Rubicon Medical Corporation
    • SCIMED, Inc.
    • Securus Medical Group, Inc.
    • Symetis SA
    • VENITI
    • Vessix Vascular, Inc.
    • Xlumena Inc.
UsernamePublicRestriction

Register